Zentek Limited (ZTEK) - Forward Price-to-Revenue Multiple

zentek.com (ZTEK) - corporate logo

The forward P/S ratio reflects the expected sales dynamics of graphene materials and security systems for plants, where the value 779.70 serves as the baseline indicator. Business resilience is driven by the integration of nano-coatings into filters and masks, which mitigates industry risks. The high authority of Zentek Ltd. (ZTEK) as the developer of ZenGUARD confirms its technological superiority and growing trust among medical professionals.

ZTEK zentek.com: Forward Price-to-Revenue Multiple in the range 04/28/2023 - 09/12/2026

Zentek - analytical breakdowns and key metrics (ZTEK)

- market price and analyst price targets:
- market capitalization indicators:
General company analysis:ZTEK (Zentek Corp)
Original product of zentek.com

Identifying a fundamental floor for Zentek Ltd. (ZTEK) requires analyzing the ratio of current market capitalization to projected revenue from the expansion of nano-coatings in medicine. The expected P/S ratio reflects the market valuation of future cash flows, allowing investors to determine the extent to which the share price is outpacing the scaling of production and the execution of B2B contracts, which is critical for assessing the reliability of this high-tech asset.

Analysis of competing companies

Price-to-Projected Revenue Ratio Intuitive Surgical Inc ISRG|Forward P/S Multiple Danaher Corporation Inc. DHR|BDX - Price-to-Projected Revenue Ratio|STERIS plc (STE) - Forward Price-to-Revenue Multiple|WST: Forward P/S Multiple|Market Cap to Future Revenue Ratio Baxter International Inc. (BAX)|MASI (masimo.com) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Stevanato Group Corp STVN|Forward Price-to-Revenue Multiple TFX (Teleflex Inc)|Merit Medical - Market Cap to Projected Revenue|Envista Holdings - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio ICUI (ICU Medical Inc)|XRAY - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio LeMaitre Corp LMAT|ATRC: Forward P/S Multiple|STAA - Market Cap to Expected Sales Ratio|NAGE (Chromadex Corp) - Forward P/S Multiple|ZimVie Inc (ZIMV) - Market Cap to Expected Sales Ratio|Forward P/S Multiple ANGO|CERS (Cerus Corporation) - Forward Price to Sales|Forward P/S Multiple TKNO (Alpha Teknova, Inc.)|Monogram Technologies (MGRM) - Market Cap to Future Revenue Ratio|STSS - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio InfuSystem INFU|Utah Med (UTMD) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple KORU Medical Systems, Inc.|Forward Price-to-Revenue Multiple NYXH|Market Cap to Future Revenue Ratio Microbot Medical MBOT|Forward Price-to-Revenue Multiple PDEX (Pro-Dex)|Market Cap to Expected Sales Ratio Elutia Inc|Forward P/S Multiple MLSS (milestonescientific.com)|NXGL: Market Cap to Projected Revenue|Retractable Tech - Forward P/S Multiple|Market Cap to Expected Sales Ratio Harvard Bioscience Inc. HBIO|FEMY: Forward P/S Multiple|MeihuaMed - Forward Price to Sales|Price-to-Projected Revenue Ratio Predictive Oncology Inc|callanjmb.com (CJMB) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Atrion Corporation (ATRI)|Market Cap to Expected Sales Ratio neurometrix.com